Product
KC1036
4 clinical trials
4 indications
Indication
Thymic TumorsIndication
Digestive System TumorsIndication
CancerIndication
Healthy SubjectsClinical trial
A Single-arm, Open, Multicenter, Phase II Study to Evaluate the Efficacy and Safety of KC1036 in the Patients With Advanced Recurrent or Metastatic Thymic TumorsStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
A Phase Ib / II Study to Evaluate the Efficacy and Safety of KC1036 in the Patients With Advanced Recurrent or Metastatic Digestive System TumorsStatus: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
A Phase I, Open-label, Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Preliminary Efficacy of KC1036 in the Patients With Advanced Recurrent or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2023-07-31
Clinical trial
A Phase I Study of KC1036 on Pharmacokinetics to Assess the Effect of High Fat Diet in Chinese Adult Healthy Subjects.Status: Completed, Estimated PCD: 2022-03-23